Related Experiment Videos
Interpretive criteria for disk diffusion susceptibility testing of sparfloxacin
1Institute of Medical Microbiology, University of Zurich, Switzerland.
Summary
New disk susceptibility test criteria for sparfloxacin were established for NCCLS and ICS/DIN methods. These criteria help determine bacterial resistance or susceptibility to sparfloxacin, aiding in effective antibiotic treatment.
Area of Science:
- Microbiology
- Pharmacology
- Clinical Diagnostics
Background:
- Accurate antibiotic susceptibility testing is crucial for guiding treatment decisions.
- Sparfloxacin is a fluoroquinolone antibiotic with activity against various bacterial pathogens.
- Standardized testing criteria are needed for reliable interpretation of sparfloxacin disk diffusion results.
Purpose of the Study:
- To determine and propose interpretive zone size breakpoints for sparfloxacin disk susceptibility tests using NCCLS and ICS/DIN methods.
- To evaluate the efficacy of 5-microgram sparfloxacin disks for routine susceptibility testing.
- To establish regression equations correlating Minimum Inhibitory Concentrations (MICs) with zone diameters for both methods.
Main Methods:
- Testing of 400 bacterial wild-type isolates with 5-microgram sparfloxacin disks.
- Determination of zone diameter breakpoints for resistance (MIC > 1 mg/L) and susceptibility (MIC ≤ 0.5 mg/L).
- Development of regression equations based on MIC and zone size data from 361 organisms.
Main Results:
- Proposed breakpoints: NCCLS ≤18 mm (resistant), ≥23 mm (susceptible); ICS/DIN ≤20 mm (resistant), ≥25 mm (susceptible).
- Sparfloxacin demonstrated 2-4 times greater activity than ciprofloxacin against Gram-positive cocci and similar activity against Gram-negative rods.
- Quality control zone diameter ranges were established for Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 29213.
Conclusions:
- The proposed criteria provide reliable interpretation for sparfloxacin disk susceptibility testing.
- Sparfloxacin exhibits potent activity, particularly against Gram-positive bacteria.
- The established regression equations allow for breakpoint adjustments based on varying pharmacokinetic parameters.